{"id":"W2033119689","doi":"10.1038/bjc.2013.735","title":"A phase II multicentre study of ziv-aflibercept in combination with cisplatin and pemetrexed in patients with previously untreated advanced/metastatic non-squamous non-small cell lung cancer","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Neurological Complications and Syndromes","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; Regeneron Pharmaceuticals; Sanofi","keywords":"Medicine; Aflibercept; Pemetrexed; Internal medicine; Nausea; Lung cancer; Adverse effect; Phases of clinical research; Oncology; Cisplatin; Progressive disease; Gastroenterology; Surgery; Chemotherapy; Bevacizumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001050493,0.0001512054,0.0005426183,0.0002033059,0.0000454682,0.00002208657,0.00008358063,0.00003298468,0.0001317057],"category_scores_gemma":[0.0000306696,0.0001186882,0.00002790757,0.0004194292,0.00004734601,0.0001924278,0.00002531491,0.0002790047,2.817141e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009984126,"about_ca_system_score_gemma":0.00009977369,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00207855,"about_ca_topic_score_gemma":0.003942221,"domain_scores_codex":[0.9986302,0.00007112131,0.0005667718,0.0002113004,0.000307323,0.0002133107],"domain_scores_gemma":[0.9987594,0.00006769277,0.0004550228,0.0001115367,0.0004853459,0.0001209252],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001299018,0.009083333,0.9103438,0.0001985406,0.00006852295,0.0002097032,0.001499177,0.0006094568,0.0003013943,1.937995e-7,0.00005835155,0.07632855],"study_design_scores_gemma":[0.05467596,0.01045549,0.9317203,0.0009564671,0.0002059973,0.00006050599,0.0004131021,0.001307093,0.00006986257,0.000003879265,0.000008196622,0.0001231051],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9963964,0.00152242,0.00003512626,0.00007904365,0.00002343118,0.001886649,0.00001304682,0.000004394386,0.00003948516],"genre_scores_gemma":[0.9986967,0.0003702226,0.0006187357,0.00006880599,0.000007970403,0.0001236878,0.000005680375,0.00002083764,0.00008734599],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07620545,"threshold_uncertainty_score":0.4839964,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008271514152304687,"score_gpt":0.2689566194956499,"score_spread":0.2606851053433452,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}